Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A new online training tool being developed by the Genomics Education Programme for scientists processing tumour samples for whole genome sequencing will feature Dr Clare Verrill, a Senior Clinical Lecturer in Pathology at the Nuffield Department of Surgical Sciences.

Many of the first healthcare professionals to use the tool will be those processing tumour samples for Genomics England’s 100,000 Genomes Project, which aims to analyse whole genome sequences from thousands of patients to develop a greater understanding of the basis of disease. The insights gained from the project will have a huge impact on histopathology.

Whole genome sequencing can only be successfully performed on DNA from tumour samples with a suitable percentage of tumour tissue and the minimum required amount of DNA. This new training tool will consist of four educational modules and one assessment module covering tumour assessment for whole genome sequencing and introducing one reliable method of assessing tumour samples in 3D. It is anticipated that histopathologists, clinical and biomedical scientists working in NHS Genomic Medicine Centres will be the first to use the tool.  

Dr Verrill, who is the Lead for Molecular Pathology at the Oxford Genomic Medicine Centre, provides an introduction to the modules and the assessment model, explaining why there is a need for standardised training. Dr Verrill said: ‘Ultimately, the goal of this training tool is to help us deliver a better service to patients. If we can assess a tumour for genomic sequencing accurately and efficiently, we will ensure that as many eligible samples as possible are selected for DNA extraction and sequencing with minimal delay or errors.

‘And of course, the goal beyond that is that, in time, we will gain a much deeper understanding of cancer at a molecular level, to better inform our patients’ diagnosis, treatment and prognostic information.’

The tool will be launched by the Genomics Education Programme in spring 2017.

Read more about the 100,000 Genomes Project.

Similar stories

Oxford University and partners win government funding to evaluate Paige Prostate Cancer Detection System

A prostate cancer detection software system to help pathologists quickly identify suspicious areas of tissue, developed by Paige, will be investigated in a multicentre clinical study led by Oxford University as part of a successful NHSx Artificial Intelligence Health and Care Award application.

Omair Shariq wins Best Clinical Paper at the American Association of Endocrine Surgeons 2021 Annual Meeting

Dr Omair Shariq, a DPhil student and clinical research fellow in the Nuffield Department of Surgical Sciences (NDS) and Oxford Centre for Diabetes Endocrinology and Metabolism (OCDEM), has received the 2021 Best Presentation for Clinical Research award during the 41st Annual Meeting of the American Association of Endocrine Surgeons (AAES), which was held virtually on 25-27 April 2021.

Artificial intelligence tool for streamlining pathology workflow

A multidisciplinary team, comprising Andrea Chatrian, Dr Richard Colling, Professor Clare Verrill, Professor Jens Rittscher and colleagues, develops an algorithm for automated requesting of additional investigation in diagnostically uncertain prostate biopsies.

New Cochrane evidence explores treatment options for chronic ear disease

A new Evidently Cochrane blog post for World Hearing Day summarises seven recent reviews on medical treatments for infection and inflammation of the middle ear.

New reporting guidelines to bridge the gap from development to implementation in clinical artificial intelligence

In a correspondence to Nature Medicine, a team of Oxford-led academics describe upcoming new guidelines to improve the reporting of early clinical stage (or first-with-human) evaluation of decision support systems driven by artificial intelligence.

Cochrane ENT awarded NIHR funding for COVID-19 project

Cochrane ENT at the Nuffield Department of Surgical Sciences has been awarded funding by the National Institute for Health Research (NIHR) to complete a suite of living systematic reviews investigating the effectiveness and safety of interventions to prevent and treat loss of smell after COVID-19 infection.

Blog posts

Celebrating women of NDS

To celebrate 100 years since women were admitted as full members of the University and on the occasion of International Women's Day, a group of inspirational women in the Nuffield Department of Surgical Sciences (NDS) reflect on their journeys, their place in Medical Sciences and their vision for the next 100 years.

The life of a research nurse: supporting the Oxford COVID-19 Vaccine Trial

Research nurses in the NHS are playing a crucial role in helping to trial new coronavirus treatments and vaccines. Three NDS research nurses stepped up to help with the fight against this new disease. Here Bhumika Patel shares her experience of working on the Oxford COVID-19 Vaccine Trial.

Why I became a Peer Supporter

The Peer Support Programme was developed in recognition of the essential role students play in supporting and encouraging one another on a day-to-day basis throughout their time at university. NDS’ own Helen Stark discusses her experience of becoming a Peer Supporter.

Racism under the microscope

As Black History Month gets underway in the UK, NDS Athena SWAN Coordinator Emily Hotine puts racism under the microscope.

In memory of Sue Bonnington

Pete Holding shares his memories of a much-loved colleague, Sue Bonnington. Based in Leicester, Sue worked remotely for the Nuffield Department of Surgical Sciences (NDS) as a ProtecT study Lead Research Nurse from 2002 to 2017.